LexDanaLexDanabeta
Inventor

DAVID BUMCROT

Inventor
US

Overview

4→
Patents
2021–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C12NMicroorganisms or enzymes24%
C12YEnzymes12%
A01KAnimal husbandry6%
C07HSugars6%
C07KPeptides6%
PatentTitleYear
12,559,755Compositions and methods for inhibiting expression of TMPRSS6 gene202612,031,133GNAQ targeted dsRNA compositions and methods for inhibiting expression202411,530,408Therapeutic compositions202211,198,876Compositions and methods for inhibiting expression of TMPRSS6 gene2021

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2021–2026Patents assigned to ALNYLAM PHARMACEUTICALS INC (4)· patent assignee history
2021–2026Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ALNYLAM PHARMACEUTICALS INC42021–2026
Locations
LocationPatentsSpan
US42021–2026